[1] World Health Organization. World malaria report 2023. Geneva: World Health Organization. 2023. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023. [2024-08-24].
[2] Chanda-Kapata P, Ntoumi F, Kapata N, Lungu P, Mucheleng’anga LA, Chakaya J, et al. Tuberculosis, HIV/AIDS and malaria health services in sub-saharan Africa - a situation analysis of the disruptions and impact of the COVID-19 pandemic. Int J Infect Dis 2022;124(S1):S41 − 6. https://doi.org/10.1016/j.ijid.2022.03.033.
[3] World Health Organization. WHO guidelines for malaria. Geneva: World Health Organization. 2024. https://www.who.int/publications/i/item/guidelines-for-malaria. [2024-08-24].
[4] Yaffee RA. A primer for panel data analysis. Connect: Information Technology at NYU 2003;8(3):1-11.
[5] Galactionova K, Tediosi F, de Savigny D, Smith T, Tanner M. Effective coverage and systems effectiveness for malaria case management in sub-Saharan African countries. PLoS One 2015;10(5):e0127818. https://doi.org/10.1371/journal.pone.0127818.
[6] Ngonghala CN. Assessing the impact of insecticide-treated nets in the face of insecticide resistance on malaria control. J Theor Biol 2022;555:111281. https://doi.org/10.1016/j.jtbi.2022.111281.
[7] Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, et al. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study. PLoS Med 2017;14(8):e1002379. https://doi.org/10.1371/journal.pmed.1002379.
[8] Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007;77(S6):79-87. https://pubmed.ncbi.nlm.nih.gov/18165478/
[9] Ye Y, Duah D. The President’s Malaria Initiative contributed to reducing malaria burden in sub-Saharan Africa between 2004 and 2014: evidence from generalized estimating equation analysis. PLoS One 2019;14(5):e0217103. https://doi.org/10.1371/journal.pone.0217103.
[10] Jakubowski A, Stearns SC, Kruk ME, Angeles G, Thirumurthy H. The US President’s Malaria Initiative and under-5 child mortality in sub-Saharan Africa: a difference-in-differences analysis. PLoS Med 2017;14(6):e1002319. https://doi.org/10.1371/journal.pmed.1002319.
[11] Langan M. Global Britain and UK aid policy towards Africa. In: Langan M, editor. Global Britain and Neo-colonialism in Africa: Brexit, ‘Development’ and Coloniality. Cham: Springer. 2024; p. 93-122. http://dx.doi.org/10.1007/978-3-031-42482-3_4.
[12] Omale UI, Ogbonnaya LU, Iyare O, Nnachi OO. System-wide governance challenges of the Ebonyi State Malaria Elimination Programme and recommendations for malaria health system strengthening: a qualitative study among stakeholders in Ebonyi state, Nigeria. BMJ Open 2024;14(5):e082598. https://doi.org/10.1136/bmjopen-2023-082598.
[13] Kapito-Tembo A, Mathanga D, Bauleni A, Nyirenda O, Pensulo P, Ali D, et al. Prevalence and clinical management of non-malarial febrile illnesses among outpatients in the era of universal malaria testing in Malawi. Am J Trop Med Hyg 2020;103(2):887 − 93. https://doi.org/10.4269/ajtmh.18-0800.
[14] Thiam S, Kimotho V, Gatonga P. Why are IPTp coverage targets so elusive in sub-Saharan Africa? A systematic review of health system barriers. Malar J 2013;12:353. https://doi.org/10.1186/1475-2875-12-353.
[15] Mehdipour P, Rajasekhar M, Dini S, Zaloumis S, Abreha T, Adam I, et al. Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. Malar J 2023;22(1):306. https://doi.org/10.1186/s12936-023-04725-w.